Login / Signup

Evaluation of palonosetron, fosaprepitant, and olanzapine as antiemetic prophylaxis for fludarabine and melphalan-based conditioning regimens prior to allogeneic hematopoietic stem cell transplants.

Riley KarpenJeremy SenSarah WallSamantha MussonJustin Tossey
Published in: Leukemia research (2023)
The combination of palonosetron, fosaprepitant, and olanzapine is an effective antiemetic regimen for patients receiving a Flu-Mel-based preparative regimen.
Keyphrases
  • chemotherapy induced
  • hematopoietic stem cell
  • high dose
  • stem cell transplantation
  • low dose